Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

MicroRNA theragnostics for the clinical management of multiple myeloma.

Ahmad N, Haider S, Jagannathan S, Anaissie E, Driscoll JJ.

Leukemia. 2014 Apr;28(4):732-8. doi: 10.1038/leu.2013.262. Epub 2013 Sep 12. Review.

PMID:
24714346
2.

The potential of miRNAs as biomarkers for multiple myeloma.

Rocci A, Hofmeister CC, Pichiorri F.

Expert Rev Mol Diagn. 2014 Nov;14(8):947-59. doi: 10.1586/14737159.2014.946906. Epub 2014 Aug 7. Review.

PMID:
25098410
3.

MicroRNAs in the pathobiology of multiple myeloma.

Lionetti M, Agnelli L, Lombardi L, Tassone P, Neri A.

Curr Cancer Drug Targets. 2012 Sep;12(7):823-37. Review.

PMID:
22671930
4.

Promises and challenges of MicroRNA-based treatment of multiple myeloma.

Tagliaferri P, Rossi M, Di Martino MT, Amodio N, Leone E, Gulla A, Neri A, Tassone P.

Curr Cancer Drug Targets. 2012 Sep;12(7):838-46. Review.

5.

Role of microRNAs from monoclonal gammopathy of undetermined significance to multiple myeloma.

Calvo KR, Landgren O, Roccaro AM, Ghobrial IM.

Semin Hematol. 2011 Jan;48(1):39-45. doi: 10.1053/j.seminhematol.2010.11.007. Review.

6.

MicroRNA: important player in the pathobiology of multiple myeloma.

Bi C, Chng WJ.

Biomed Res Int. 2014;2014:521586. doi: 10.1155/2014/521586. Epub 2014 Jun 3. Review.

7.

MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival.

Chi J, Ballabio E, Chen XH, Kušec R, Taylor S, Hay D, Tramonti D, Saunders NJ, Littlewood T, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Lawrie CH.

Biol Direct. 2011 May 18;6:23. doi: 10.1186/1745-6150-6-23.

8.

From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario.

Rossi M, Amodio N, Di Martino MT, Caracciolo D, Tagliaferri P, Tassone P.

Curr Drug Targets. 2013 Sep;14(10):1144-9. Review.

PMID:
23834146
9.

Aberrant microRNA expression in multiple myeloma.

Dimopoulos K, Gimsing P, Grønbæk K.

Eur J Haematol. 2013 Aug;91(2):95-105. doi: 10.1111/ejh.12124. Epub 2013 Jun 5. Review.

PMID:
23586898
10.

Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.

Amodio N, Di Martino MT, Neri A, Tagliaferri P, Tassone P.

Expert Opin Biol Ther. 2013 Jun;13 Suppl 1:S125-37. doi: 10.1517/14712598.2013.796356. Epub 2013 May 22. Review.

PMID:
23692413
11.

Personalized oncology: recent advances and future challenges.

Kalia M.

Metabolism. 2013 Jan;62 Suppl 1:S11-4. doi: 10.1016/j.metabol.2012.08.016. Epub 2012 Sep 19. Review.

PMID:
22999010
12.

miRNA deregulation in multiple myeloma.

Bi CL, Chng WJ.

Chin Med J (Engl). 2011 Oct;124(19):3164-9. Review.

13.

MicroRNAs in body fluids--the mix of hormones and biomarkers.

Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA.

Nat Rev Clin Oncol. 2011 Jun 7;8(8):467-77. doi: 10.1038/nrclinonc.2011.76. Review.

14.

Prognostic and predictive biomarkers: tools in personalized oncology.

Nalejska E, Mączyńska E, Lewandowska MA.

Mol Diagn Ther. 2014 Jun;18(3):273-84. doi: 10.1007/s40291-013-0077-9. Review.

15.

Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.

Albulescu R, Neagu M, Albulescu L, Tanase C.

Expert Rev Mol Diagn. 2011 Jan;11(1):101-20. doi: 10.1586/erm.10.106. Review.

PMID:
21171925
16.

Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma.

Huang JJ, Yu J, Li JY, Liu YT, Zhong RQ.

Med Oncol. 2012 Dec;29(4):2402-8. doi: 10.1007/s12032-012-0210-3. Epub 2012 Mar 24.

PMID:
22447484
17.

Multiple myeloma.

Harousseau JL, Shaughnessy J Jr, Richardson P.

Hematology Am Soc Hematol Educ Program. 2004:237-56. Review.

PMID:
15561686
18.

Improved risk stratification in myeloma using a microRNA-based classifier.

Wu P, Agnelli L, Walker BA, Todoerti K, Lionetti M, Johnson DC, Kaiser M, Mirabella F, Wardell C, Gregory WM, Davies FE, Brewer D, Neri A, Morgan GJ.

Br J Haematol. 2013 Aug;162(3):348-59. doi: 10.1111/bjh.12394. Epub 2013 May 30.

PMID:
23718138
19.

MicroRNA and multiple myeloma: from laboratory findings to translational therapeutic approaches.

Rossi M, Amodio N, Di Martino MT, Tagliaferri P, Tassone P, Cho WC.

Curr Pharm Biotechnol. 2014;15(5):459-67. Review.

PMID:
24846067
20.

Role of microRNAs in gynecological pathology.

Gilabert-Estelles J, Braza-Boils A, Ramon LA, Zorio E, Medina P, Espana F, Estelles A.

Curr Med Chem. 2012;19(15):2406-13. Review.

PMID:
22455593
Items per page

Supplemental Content

Write to the Help Desk